Yumeng M. Xing

State Key Laboratory Of Physical Chemistry Of Solid Surfaces
Xiamen, 361005, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Precisely deliver toll-like receptor agonists using a dual-responsive nanovaccine for effective cancer immunotherapy.

Precisely deliver toll-like receptor agonists using a dual-responsive nanovaccine for effective cancer immunotherapy.

Journal: Biomaterials

Published: March 24, 2025

Precise and controllable synthesis of ultra-stable gold nanoparticles based on polymer templates for miRNA detection.

Precise and controllable synthesis of ultra-stable gold nanoparticles based on polymer templates for miRNA detection.

Journal: Chemical communications (Cambridge, England)

Published: February 07, 2025

A Bifunctional Lysosome-Targeting Chimera Nanoplatform for Tumor-Selective Protein Degradation and Enhanced Cancer Immunotherapy.

A Bifunctional Lysosome-Targeting Chimera Nanoplatform for Tumor-Selective Protein Degradation and Enhanced Cancer Immunotherapy.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: November 19, 2024

An Injectable Photothermal-Fusing Hydrogel: Achieving Temperature-Controllable Mild Photothermal Therapy to Reverse Chemotherapy-Induced Immune Tolerance.

An Injectable Photothermal-Fusing Hydrogel: Achieving Temperature-Controllable Mild Photothermal Therapy to Reverse Chemotherapy-Induced Immune Tolerance.

Journal: Nano letters

Published: October 02, 2024

Lysosome Targeted Nanoparticle Aggregation Reverses Immunosuppressive Tumor Microenvironment for Cancer Immunotherapy.

Lysosome Targeted Nanoparticle Aggregation Reverses Immunosuppressive Tumor Microenvironment for Cancer Immunotherapy.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: August 26, 2024

Precisely Activating cGAS-STING Pathway with a Novel Peptide-Based Nanoagonist to Potentiate Immune Checkpoint Blockade Cancer Immunotherapy.

Precisely Activating cGAS-STING Pathway with a Novel Peptide-Based Nanoagonist to Potentiate Immune Checkpoint Blockade Cancer Immunotherapy.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: December 11, 2023

Remodeling Tumor Immunogenicity with Dual-Activatable Binary CRISPR Nanomedicine for Cancer Immunotherapy.

Remodeling Tumor Immunogenicity with Dual-Activatable Binary CRISPR Nanomedicine for Cancer Immunotherapy.

Journal: ACS nano

Published: March 10, 2023

Recombinant human kallistatin inhibits angiogenesis by blocking VEGF signaling pathway.

Recombinant human kallistatin inhibits angiogenesis by blocking VEGF signaling pathway.

Journal: Journal of cellular biochemistry

Published: March 19, 2013

Showing 1-8 of 8

Last Updated: 09/26/2026